<DOC>
	<DOCNO>NCT00766480</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue laboratory patient cancer may help doctor learn change occur DNA identify biomarkers related cancer . It may also help doctor predict patient respond treatment . PURPOSE : This clinical trial study tissue sample predict well chemotherapy radiation therapy kill cancer cell patient squamous cell carcinoma esophagus .</brief_summary>
	<brief_title>Study Tissue Samples Predicting How Well Chemotherapy Radiation Therapy Will Kill Cancer Cells Patients With Squamous Cell Carcinoma Esophagus</brief_title>
	<detailed_description>OBJECTIVES : - To search chemoradiosensitivity-related gene use pre-treatment biopsy sample patient esophageal squamous cell carcinoma treat cisplatin , fluorouracil , concurrent radiotherapy . - To establish algorithm prediction chemoradiosensitivity patient . OUTLINE : Patients receive 1 follow treatment regimen : - Regimen 1 : Patients receive low-dose cisplatin IV day 1 29 low-dose fluorouracil IV day 1-4 29-32 . Patients also undergo concurrent radiotherapy day 1-4 29-32 . Patients undergo salvage surgery need . - Regimen 2 : Patients receive high-dose cisplatin IV day 1 29 high-dose fluorouracil IV day 1-4 29-32 . Patients also undergo concurrent radiotherapy salvage surgery regimen 1 . Pre-operative biopsy sample analyze DNA microarray chip establish algorithm prediction chemoradiosensitivity . After completion study therapy , patient follow 12 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma thoracic esophagus Stage IIA , IIB , III ( except T4 ) disease Tumor diameter &lt; 8 cm No tumor extension cervical esophagus cardia stomach No multiple different histological type cancer PATIENT CHARACTERISTICS : ECOG performance status 01 WBC ≥ 4,000/mm³ Absolute neutrophil count ≥ 2,000/mm³ Platelet count ≥ 100,000/mm³ Hemoglobin ≥ 10 g/dL AST ALT ≤ 100 IU/L Total serum bilirubin ≤ 1.5 mg/dL Creatinine ≤ 1.2 mg/dL Creatinine clearance ≥ 60mL/min SpO_2 ( room air ) ≥ 95 % Not pregnant nursing No abnormal ECG finding require treatment No interstitial pneumonitis pulmonary fibrosis No severe complication ( e.g. , heart failure , renal failure , hepatic failure , uncontrollable diabetes mellitus ) No collagen disease ( e.g. , PSS dermatomyositis ) No mental disease No active bacterial infection No virus infection ( i.e. , HBV , HCV , PTHA , HIV ) PRIOR CONCURRENT THERAPY : No prior surgery esophageal cancer No prior chemotherapy No prior chest radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>stage IIA esophageal cancer</keyword>
	<keyword>stage IIB esophageal cancer</keyword>
	<keyword>stage IIIA esophageal cancer</keyword>
	<keyword>stage IIIB esophageal cancer</keyword>
	<keyword>stage IIIC esophageal cancer</keyword>
</DOC>